Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Can-Fite Biopharma Ltd. > Hedge Fund Holdings

Can-Fite Biopharma Ltd. ()

Market is closed
Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Sabby Capital

Hal Mintz

 779,744 $818,731 1.48%
Insider Monkey Quarterly Strategy
+427.7% Insider Monkey Quarterly Strategy
+163.1% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
400%
200%
0%
Subscribe Now

Returns since its inception in May 2014 (through August 15th, 2025)